Acetaminophen And Codeine Phosphate Solution
FDA Label NDC 0121-0504

70 label sections · Submitted to the FDA by Pai Holdings, Llc Dba Pai Pharma · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Pai Holdings, Llc Dba Pai Pharma for the product Acetaminophen And Codeine Phosphate (NDC 0121-0504). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding risk of accidental overdose and death due to medication errors, addiction, abuse, and misuse, life-threatening respiratory depression, accidental ingestion, risks from concomitant use with benzodiazepines or other cns depressants, neonatal opioid withdrawal syndrome, opioid analgesic risk evaluation and mitigation strategy (rems), ultra-rapid metabolism of codeine and other risk factors for life-threatening respiratory depression in children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.